Skip to content

The Association of SERPINA1 Gene Disturbance in Patients With Lung and Gum Disorders

Evaluation of SERPINA1 Gene Polymorphisms in COPD as a Risk Factor for Periodontitis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02498938
Acronym
SA1PLG
Enrollment
60
Registered
2015-07-15
Start date
2015-03-31
Completion date
2015-12-31
Last updated
2016-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Generalized Chronic Periodontitis, Pulmonary Disease, Chronic Obstructive

Keywords

Pulmonary disease,chronic obstructive,, generalized chronic periodontitis, SERPINA1 gene polymorphism

Brief summary

Chronic obstructive pulmonary disease and periodontitis are chronic inflammatory diseases. The study aims to determine if the genetic polymorphism of SERPINA1 gene in patients with COPD serve as a risk factor for developing periodontitis.

Detailed description

periodontitis is a polymicrobial inflammatory disease caused by various modifiable and non-modifiable risk factors. the non-modifiable risk factors include genetic polymorphisms like the gene coding for alpha-1-antitrypsinase COPD is a chronic inflammatory disease characterized by deterioration of lung function due to loss of elasticity of the lungs. SERPINA1 gene product has a protective role on the connective tissue components of both lungs and gums. Hence, this study tries to determine if the gene polymorphism in COPD serves as a risk factor for developing periodontitis.

Interventions

GENETICSERPINA1 gene

2ml blood sample collected from patients to extract DNA for assessment of SERPINA1 gene polymorphism

Sponsors

Panineeya Mahavidyalaya Institute of Dental Sciences & Research Centre
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
30 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Male and female patients aged between 30-70yrs diagnosed with COPD and chronic periodontitis who are willing to participate in the study.

Exclusion criteria

* Pateints with other systemic disorders * patients not willing to participate in the study

Design outcomes

Primary

MeasureTime frameDescription
SERPINA1 gene polymorphism9 monthsof blood samples and running samples by PCR

Countries

India

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026